Tenofovir Alafenamide RSR Isomer - Names and Identifiers
Tenofovir Alafenamide RSR Isomer - Physico-chemical Properties
Molecular Formula | C21H29N6O7P
|
Molar Mass | 508.464721 |
Storage Condition | 2-8°C |
Tenofovir Alafenamide RSR Isomer - Introduction
isopropyl ((S)-(((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate(Isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate) is a chemical substance. The following is a description of the nature, use, preparation and safety information of the substance:
Nature:
-Molecular formula: C23H31N6O7P
-Molecular weight: 530.51g/mol
-Appearance: White solid
-Melting point: About 140-150 ° C
Use:
isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate is mainly used in the field of medicine, it is an intermediate of antiviral drugs. It has the function of inhibiting viral replication and is commonly used in antiretroviral (such as HIV) drug research and development.
Preparation Method:
isopropyl (((S)-(((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl) the preparation of D-alaninate involves a multi-step reaction and synthetic route. The specific preparation method may involve chemical synthesis and conversion reactions, which need to be operated by professional chemical laboratories and professional technicians.
Safety Information:
About the safety of isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate, there may be a lack of specific research data at this time, so caution is needed. Any handling and use of the substance shall be in accordance with the relevant safety practices. Wear appropriate protective equipment (such as lab coats, gloves, and goggles) when performing chemical experiments. Local laboratory procedures should be followed and national and international safety standards must be followed. If this substance is to be used, it is recommended that it be operated under appropriate professional guidance.
Last Update:2024-04-09 19:05:59